Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The roots of automated hematology began with manual microscopy and laborious cell counting techniques. Using the Coulter principle and advances in laboratory methodology, automated hematology is now rapid and inexpensive with the complete blood cell count (CBC) being one of the most commonly ordered tests in medicine.
This chapter describes the principles of automated hematology, including how we measure red blood cells (RBCs), white blood cells (WBCs), and platelets from whole blood. Next, the laboratory parameters that are derived from the measurement of RBCs, WBCs, and platelets are discussed. These include standard laboratory measurements of the CBC which help describe anemia, such as the mean corpuscular volume (MCV), to newer measurements which quantitate immature granulocytes (IG), immature platelets (IPF), and immature reticulocytes (IRF). The uses of recently introduced laboratory parameters in automated hematology are also described.
Hematology has undergone a revolution in technical methods, moving from manual counting to automated techniques. Red blood cells appeared as small red globules under the microscope first invented by van Leeuwenhoek over 300 years ago. The first blood count was developed by Karl Vierordt at the University of Tubingen in 1852, by which a fixed amount of blood was drawn into a capillary tube, spread on a slide, stained, and counted. Based on that principle the hemocytometer was developed, which uses a ruled counting chamber that contains a fixed amount of blood. The chamber’s etched perpendicular grids allow for easier enumeration of the cells. Despite its many drawbacks, the hemocytometer is easy to use and gives better consistency than other manual methods. In the early 1900s, the red blood cell (RBC) count, white blood cell (WBC) count, and the platelet (PLT) count were performed using such counting chambers. The hemoglobin concentration (Hb) was analyzed by the cyanmethemoglobin method, still considered the reference method today. The packed cell volume or hematocrit (HCT) was measured using high-speed centrifugation of a column of blood. This was performed either in a sealed microcapillary tube, also known as the spun hematocrit, or in a specifically designed Wintrobe tube. Finally, the WBC differential was enumerated by the type of WBC (e.g., granulocyte, lymphocyte, monocyte), examining 100 to 200 individual leukocytes on a stained peripheral blood smear. These early methods were laborious, and in particular for manual cell counts, imprecise.
Wintrobe developed a calculated set of RBC indices in 1932 that estimated the RBC size and hemoglobin content based on the RBC count, Hb, and HCT. The RBC indices included the mean corpuscular volume (MCV), which is the volume of the average erythrocyte measure in femtoliters (fL), the mean corpuscular hemoglobin (MCH), which is the hemoglobin content of the average erythrocyte measured in picograms (pg), and the mean corpuscular hemoglobin concentration (MCHC), which is the hemoglobin concentration within circulating erythrocytes as measured in grams of hemoglobin per deciliters of RBCs.
Wallace and Joseph Coulter patented a device in the 1950s using electrical impedance to count red and white blood cells. In this method, blood is diluted in a solution that conducts current, such as isotonic saline. A vacuum then draws this solution containing cells through a small aperture located between two electrodes connected across a direct current potential. The resistance between the electrodes increases as each cell passes through this orifice ( Fig. 74.1 ). Cells are poor electrical conductors and generate a transient increase in impedance that results in an electrical pulse. Thus the number of pulses results in the cell count. The amplitude of the pulse is proportional to the volume of that cell. Thresholds could be set such that only particles within a specified range would be counted. For example, a cell count on a diluted whole blood sample could generate an RBC count given that there are approximately 1000 RBCs for every WBC, and platelets can be eliminated by selecting an appropriate lower pulse height threshold to exclude smaller cells. To yield a WBC count, lysing agents would be added to remove RBCs, and then WBCs could be counted using appropriate size thresholds.
The first semi automated systems used separate RBC and WBC manual dilutions. Added to the WBC dilution was a combination lysing agent and potassium ferricyanide solution; this allowed for the enumeration of WBCs and the measurement of hemoglobin, using the spectrophotometric measurement of cyanmethemoglobin. The RBC indices were calculated manually as shown above.
The first multichannel automated hematology analyzers were in use in the 1960s. In these instruments, anticoagulated whole blood was aspirated into the analyzer and automatically aliquoted and diluted into RBC and WBC chambers for cell counting and sizing using impedance apertures, and into a cuvette for hemoglobin determination using the cyanmethemoglobin reaction (see below). The RBC indices were automatically calculated. To correct for coincidence, that is when two or more cells are so close together that they are counted as one cell, a coincidence correction was automatically performed on the raw impedance count. These instruments directly measured the RBC and the MCV, and thus the HCT can be calculated as follows:
By combining a flow device with a laser, Dittrich and Gohde developed a light based high-throughput cytometry instrument, making it possible to count large numbers of cells within a short time period. These multichannel instruments revolutionized the CBC, enabling fast turnaround time, high throughput and lower cost. The platelet count was not included in the first automated CBC, because the aperture resolution on these early instruments could not adequately separate RBCs from platelets.
By the 1970s, improvement of the cell counting apertures led to the automated enumeration of platelets in whole blood samples. Technical problems that needed to be overcome included the nonaxial passage of RBCs through the aperture and the recounting of RBCs that nicked the edge of the aperture; these problems resulted in a small proportion of RBCs resembling platelets in terms of cell size. This could lead to overestimates of the platelet count. These problems were corrected by better apertures that were smaller in diameter and longer in length, thus centralizing the flow of particles. Hydrodynamic focusing was developed in which the cells are forced to enter the aperture in a single file through the center of the aperture, ensuring more accurate cell sizing. At the exit of the aperture, “sweep flow” of the diluent quickly removes counted particles so that the RBCs cannot recirculate and nick the aperture and be erroneously recounted as platelet-size particles. Some analyzers have a von Behrens transducer which minimizes recirculation of cells by forcing the exit stream through a second aperture, and trapping cells behind a plate. Finally, pulse editing eliminates pulses from cells that travel a nonaxial path through the aperture for both platelets and RBCs. An important point to note is that poikilocytes, such as schistocytes or other non-normal erythrocyte shapes, often have pulses with aberrant shapes that are edited out of the MCV computation. In spite of these improvements, impedance methods have a limited linear range for the sizing of particles. This failure to accurately enumerate the smallest and largest erythrocytes can lead to an overestimation of microcytosis and an underestimation of macrocytosis, resulting in an MCHC with limited range.
George and Groner also implemented light scattering in flow cytometers in the 1970s, allowing for the discrimination of different types of leukocytes based on size and light scatter properties. Using light scatter measurements at two different angles allowed for the measurement of red cell size (low angle light scatter) and hemoglobin content (high angle scatter) after isovolumetric sphering of cells.
The hemocytometer is still used today in low-resource laboratories around the world because of its simplicity and low cost.
The principles of automated instruments include electrical current (impedance), light absorption, and fluorescence. Automated hematology analyzers primarily use impedance counting to enumerate RBCs ( Table 74.1 ). For example, in Beckman Coulter analyzers, RBCs are enumerated as particles within the RBC/PLT aperture with a cell volume ranging from approximately 36 to 360 fL. A plot of frequency versus size generates an RBC volume histogram that typically has a Gaussian distribution ( Fig. 74.2 ). Aberrant pulses are excluded using pulse editing software. The MCV and RBC distribution width or red cell distribution width (RDW) (coefficient of variation [CV] of the RBC volume distribution) are either derived from the RBC histogram or as direct measurements (see Table 74.1 ). Analysis of the RBC histogram can give clues to a patient’s medical condition, including: the presence of spherocytes or RBC fragments (left shoulder indicating RBCs with small size), a dimorphic curve indicating the presence of two populations of RBCs, macrocytes or reticulocytes (right shoulder indicating RBCs of large size), or RBC agglutinins (RBC population to extreme right indicating clumping of RBCs).
Parameters [Units of Measure] | Method | Formula for Calculation |
---|---|---|
WBC count [/μL or ×10 9 /L] | Measured | |
WBC differential [%, /μL, ×10 9 /L] | Measured, calculated | |
RBC count [/μL or ×10 12 /L] | Measured | |
Hb [g/dL, or g/L] | Measured | |
HCT [%] a | Measured | |
Calculated | HCT = (RBC × MCV)/10 | |
MCH [pg = g × 10 –12 ] | Calculated | MCH = Hb g/dL × 10/RBC (millions/μL) |
MCHC [%] | Calculated | MCHC = Hb g/dL × 100/HCT(%) |
MCV [fL] a | Measured | |
Calculated | MCV (fL) = 10 × HCT (%)/RBC (millions/μL) | |
RDW [% or fL] | Calculated | CV or SD |
Reticulocyte count [/μL or × 10 12 /L] | Measured | |
IRF [%] | Measured | |
Reticulocyte hemoglobin content [pg] | Measured | |
PLT count [/μL or × 10 9 /L] | Measured | |
MPV [fL] | Measured | |
IPF [%] | Measured |
a Some analyzers directly measure, while others calculate these parameters.
Light scatter also can be used to count RBCs with a predetermined size range (e.g., 30 to 180 fL) used to yield an RBC count. To accomplish this, RBCs must first be isovolumetrically sphered and fixed, and thus low and high forward angle light scatter yield RBC size and refractive index (directly proportional to Hb content), respectively. Thus an RBC cytogram can be constructed (RBC volume and Hb concentration) for each individual erythrocyte. Subsequent RBC volume and Hb histograms can be generated and the mean of the directly measured Hb content per RBC, mean of the directly measured Hb concentration, the cellular hemoglobin content distribution width, and the cellular hemoglobin concentration distribution width can be derived. Light scatter also allows better discrimination of WBCs from unlysed RBCs and nucleated red blood cells (nRBCs).
Fluorescence is utilized in modern hematology analyzers to stain nucleic acid RNA and DNA for the measurement of reticulocytes, reticulocyte hemoglobin, immature granulocytes, immature platelets fraction, nucleated RBCs, and WBC differential counts including blasts and abnormal lymphocytes. A few studies have demonstrated that fluorescence is more accurate and reliable than impedance or light scatter for platelet measurements.
The normal range of RBC parameters may vary by age, sex, and geographic location. For example, newborns have higher RBC counts, Hb, and HCT levels because of the relative hypoxic environment in the uterus. Males usually have higher counts than females. People living at higher elevations typically have higher counts than people at sea level because of the relatively lower oxygen concentration found at higher elevations.
The RBC count is the number of RBCs per microliter of blood, expressed as number per microliter or number per 10 12 /L. It is a direct count by the hematology analyzer (see Table 74.1 ). An increased RBC count (i.e., erythrocytosis) can be seen in hemoglobinopathies, in reactive conditions such as hypoxic environments (e.g., high elevation, smoking, chronic lung diseases), or erythropoietin-producing tumors. Erythrocytosis also can be seen in myeloproliferative neoplasms (e.g., polycythemia vera). A decreased RBC is indicative of anemia.
The Hb concentration is the concentration of Hb in whole blood, expressed as grams per deciliter (g/dL). The Hb concentration in a whole blood sample is most often determined by using a flow-through cuvette in a multiparameter hematology instrument. A diluted and lysed blood sample is introduced into a cuvette and, depending on the method, a specific reagent is added to convert Hb into a measurable chromogen (see Table 74.1 ).
The recommended method by the International Committee for Standardization in Haematology (ICSH) for measuring Hb concentration is cyanmethemoglobin, which is measured colorimetrically. Erythrocytes contain a mixture of Hb, oxyhemoglobin, carboxyhemoglobin, and other minor forms. All forms of Hb are converted to cyanmethemoglobin, which is then measured at its absorbance of 540 nm by a spectrophotometer.
The cyanide-free alternatives of measuring Hb are used in some analyzers. One example is sodium lauryl sulfate used by Sysmex hematology instruments. The reagent lyses RBCs, starts the chemical reaction by altering the globin conformation, and then oxidizes the iron within the heme group, which is followed by sodium lauryl sulphate binding to iron to form a stable, colored sodium lauryl sulphate–Hb complex, which is measured photometrically.
An increase in Hb can be physiologic, such as dehydration, or pathologic, such as polycythemia, reactive, or neoplastic. Decreased Hb is indicative of anemia.
HCT is the portion of blood occupied by RBCs (%). It can be directly measured by centrifugation or calculated from the RBC count and MCV as HCT = (RBC MCV)/10. It also is measured directly by some instruments (see Table 74.1 ).
A change of HCT is usually coincident with RBC count and Hb. Increased HCT can be seen in polycythemia, either reactive or neoplastic. Decreased HCT is seen in anemia.
The “rule of three” (RBC 3 = Hb, Hb 3 = HCT) is only useful when the RBCs are normal in size and shape.
The MCV is the average volume (size) of the RBCs. It is directly measured from the RBC histogram. However, it can also be calculated as MCV (fL) = 10 HCT (%)/RBC (millions/μL).
Anemia can be classified based on MCV, as discussed in Chapter 76 . An anemia with a decreased MCV is a microcytic anemia. An anemia with an increased MCV is a macrocytic anemia. An anemia with a normal MCV is a normocytic anemia. Each type of anemia raises a particular set of differential diagnoses. Of note, some anemias may manifest as more than one form of anemia. For example, anemia of chronic disease/inflammation is often normocytic; however, it can manifest as a microcytic anemia.
The MCH is the average Hb content per RBC, expressed as picograms (pg = g 10 −12 ). It is calculated as MCH = Hb (g/dL) 10/RBC (millions/μL).
The MCHC is the average Hb concentration per unit volume of RBCs, expressed as a percentage. It is calculated as MCHC = Hb (g/dL) 100/HCT (%).
MCHC is commonly used to determine hypochromasia, as it is unaffected by the MCV, while MCH can increase or decrease in parallel to the MCV. , A decrease in MCHC is typically used as an indicator for iron deficiency. Increased MCHC is a clue to increased spherocytes, as seen in either hereditary spherocytosis or autoimmune hemolytic anemia. The MCHC is also increased in homozygous sickle cell or Hb C disease.
The RDW is the direct measurement of RBC size variation. Depending on the analyzer, this calculated parameter represents either the CV (%) or standard deviation (SD) (fL) (see Table 74.1 ). It reflects the degree of anisocytosis. For example, a larger RDW is present in iron deficiency anemia compared to thalassemia trait.
nRBCs are traditionally counted by the manual differential count. Most major hematology analyzers can now enumerate nRBCs and perform the WBC correction automatically with excellent precision and good correlation among the major hematology analyzers. , For example, some hematology analyzers use a nucleic acid fluorescent dye to stain the residual nucleic acids within the nRBCs, enabling easy separation from WBCs based on their weaker fluorescent intensity.
nRBCs or erythroblasts are normally present in the peripheral blood of newborns. They typically disappear within a week or so in healthy term babies. However, they can persist in pathologic conditions that stress the bone marrow such as with infections, hemolytic anemias, and hypoxic conditions. nRBCs in adults is indicative of a pathologic condition. Acute bleeding, hemolysis, hemoglobinopathies, bone marrow replacement by metastatic neoplasm, fibrosis, and primary myeloid neoplasms are a few examples. A markedly increased number of nRBCs correlates with poor prognosis in some conditions such as with patients undergoing cardiothoracic surgery. Persistence of nRBCs in the peripheral blood is a poor prognostic indicator in patient status after stem cell transplantation.
As discussed in more detail in Chapter 76 , the presence of schistocytes or RBC fragments usually raises a differential diagnosis of several serious medical conditions; that is, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and intravascular mechanical damage to the RBCs.
Schistocytes are traditionally counted by manual microscopy. A few automated hematology analyzers such as Siemens ADVIA 2120 and Sysmex 2100 have the capability of counting schistocytes based on cell size and Hb content. However, the automated schistocyte count has a reasonable sensitivity, but less than optimal specificity. This function is not widely used yet in clinical laboratories.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here